INCR 1.49 (+11.19%)
IL0011063760Drug ManufacturersDrug Manufacturers - Specialty & Generic

Intercure (INCR) Competitor Comparison

We are evaluating the key criteria listed to compare Intercure (INCR) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 10 years - INCR ranking 0 / 54

These are the competitors of Intercure in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 10 years
1. ANI Pharmaceuticals ANIP
86.01
2. Theratechnologies THTX
35.95
3. Evolus EOLS
30.99
4. ProPhase Labs PRPH
14.25
5. Eagle Pharmaceuticals EGRX
9.12
6. Green Thumb Industries R9U2.F
9.01
7. Alvotech ALVO
8.77
8. Regencell Bioscience Holdings RGC
8.01
9. Alimera Sciences ALIM
7.61
10. Vifor Pharma G2AB.F
7.23
11. Phibro Animal Health PAHC
6.71
12. PetIQ PETQ
5.4
13. Emergent BioSolutions EBS
5.08
14. Kolinpharma KIP.MI
4.84
15. Linc LNC
4.75
16. Avadel Pharmaceuticals AVDL
3.83
17. Ironwood Pharmaceuticals IRWD
3.77
18. Societal CDMO SCTL
3.72
19. Ayr Wellness 3KJB.F
3.68
20. Kamada KMDA
3.63
21. Cumberland Pharmaceuticals CPIX
3.28
22. Organogenesis Holdings ORGO
3.26
23. Elanco Animal Health ELAN
3.05
24. Curaleaf Holdings CURLF
2.97
25. Embecta EMBC
2.93
26. Taro Pharmaceutical Industries TARO
2.87
27. Amneal Pharmaceuticals AMRX
2.87
28. Cronos Group CRON
2.66
29. Procaps Group PROC
2.57
30. Journey Medical DERM
2.47
31. Tilray Brands TLRY
2.3
32. Neoleukin Therapeutics NLTX
2.29
33. Teva Pharmaceutical Industries TEVA
2.29
34. Pacira BioSciences PCRX
2.28
35. Catalent CTLT
2.12
36. Perrigo PRGO
1.97
37. Alpha Teknova TKNO
1.92
38. Jupiter Wellness JUPW
1.84
39. Biofrontera BFRI
1.78
40. Flora Growth FLGC
1.77
41. Ascend Wellness Holdings AAWH
1.76
42. OptiNose OPTN
1.72
43. Zynerba Pharmaceuticals ZYNE
1.63
44. Clever Leaves Holdings CLVR
1.62
45. Solid Biosciences SLDB
1.6
46. Universe Pharmaceuticals UPC
1.58
47. Relmada Therapeutics RLMD
1.55
48. Bausch Health Companies BHC
1.54
49. Collegium Pharmaceutical COLL
1.42
50. SCYNEXIS SCYX
1.37
51. Supernus Pharmaceuticals SUPN
1.2
52. Zoetis ZTS
1.01
53. Amphastar Pharmaceuticals AMPH
0.81
54. Harrow Health HROW
0.54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.